Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Prevenar

Prevenar

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Prevenar

15 trials tracked of Prevenar: 11 in phase 3 or 4 and 4 with published results. The most-cited published study has 271 citations.

15Trials tracked
11Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 4 2 Phase 3 9 Phase 2 3 Other / NA 1
  1. Phase 3 Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine. Completed · 271 cited
  2. Phase 3 Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib Completed · 134 cited
  3. Phase 3 Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine Completed · 93 cited
  4. Phase 3 Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines Completed · 31 cited
  5. Phase 4 Safety and Immunogenicity of Sequential Pneumococcal Immunization in Preschool Asthmatics Completed
  6. Phase 4 A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria Completed
Show 9 more trials
  1. Phase 3 Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine Completed
  2. Phase 3 Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™ Completed
  3. Phase 3 Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines Completed
  4. Phase 3 Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants Completed
  5. Phase 3 Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants Completed
  6. Phase 2 Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine Completed
  7. Phase 2 Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines Completed
  8. Phase 2 Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants Completed
  9. N/A Prevenar (13v) Infant Drug Use Investigation Completed

Showing the 15 most-cited and recently-updated of 15 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.